>$100,000

BC SR&ED Financing

Funding Details Type of Facility: SR&ED Financing Days to Fund: 19 Use of Funds: Millions of dollars have been invested in this company’s breakthrough treatment.  To pay for significant expenses associated with certification, Venbridge provided a bridge facility to assist the company to extend its runway to commercialization. Company Background: This company is developing platform … Read more

>$250,000

ON SR&ED Financing

Funding Details Type of Facility: SR&ED Financing Days to Fund: 8 Use of Funds: Being in the healthcare technology space during Covid has resulted in an unexpected acceleration of the business.  Venbridge helped to company meet demand and grow revenue without equity dilution. Company Background: This company aims to disrupt digital diagnostics and therapeutics by … Read more

>$250,000

Project Description Type of Facility: SR&ED Financing Days to Fund: 12 Use of Funds: Developing biopharmaceuticals requires deep pockets and patients.  After selling solutions to governments and corporations around the world, the company needed additional funding to invest even more heavily in R&D.  The SR&ED loan was provided in multiple disbursements to meet their cash … Read more

>$100,000

Project Description Type of Facility: SR&ED Financing Days to Fund: 17 Use of Funds: The company was expecting a very large contract from an international strategic customer.  There was an important trade show where the international brand would launch the solution.  The company needed the funds for marketing and to continue operations until the large … Read more

> $500,000

Project Description Type of Facility: SR&ED Financing Days to Fund: 21 Use of Funds: This company has long-term contract with automotive and other customers.  Typically, there is a significant R&D investment to design and manufacture the solution needed.  It can take 6 to 12 months of engineering, and up to 2 years before delivery of … Read more

Enquire about our services

  • This field is for validation purposes and should be left unchanged.